APA (7th ed.) Citation

JD, O., GC, C., EM, Z., JR, H., A, S., KL, W., . . . FL, B. (2026). Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumors. Journal of medical economics, 29(1), 1046. https://doi.org/10.1080/13696998.2026.2644108

Chicago Style (17th ed.) Citation

JD, Ortendahl, et al. "Costs and Benefits of Whole-exome, Whole-transcriptome Sequencing Versus 50-gene Panels for Genomic Profiling in Solid Tumors." Journal of Medical Economics 29, no. 1 (2026): 1046. https://doi.org/10.1080/13696998.2026.2644108.

MLA (9th ed.) Citation

JD, Ortendahl, et al. "Costs and Benefits of Whole-exome, Whole-transcriptome Sequencing Versus 50-gene Panels for Genomic Profiling in Solid Tumors." Journal of Medical Economics, vol. 29, no. 1, 2026, p. 1046, https://doi.org/10.1080/13696998.2026.2644108.